期刊文献+

肿瘤相关成纤维细胞对乳腺癌干细胞的影响及机制研究进展 被引量:4

The latest research progress of effects of carcinoma-associated fibroblasts on breast cancer stem cells and its mechanism
原文传递
导出
摘要 目的总结肿瘤相关成纤维细胞(CAFs)对乳腺癌干细胞的影响及其机制的研究现状。方法对近年来有关CAFs与乳腺癌干细胞关系研究的相关文献进行综述。结果 CAFs是乳腺癌间质中最主要的细胞类型,而肿瘤间质又是肿瘤微环境的重要组成部分,肿瘤微环境影响乳腺癌细胞的增殖、黏附、侵袭、转移及复发,乳腺癌组织中有一小群具有自我更新及多向分化潜能的干细胞可能与乳腺癌发生、发展密切相关。乳腺癌干细胞内部表型存在异质性,其可能与乳腺癌的转移过程相关。CAFs可通过上皮间质转化的过程对乳腺癌干细胞的形成起促进作用,同时也影响肿瘤干细胞内部的表型转化,但仍需进一步的研究证据。结论 CAFs在乳腺癌干细胞形成及表型转化过程中扮演重要角色,为探究乳腺癌的治疗途径提供了一种新思路。 Objective To summarize research status and mechanism about effects of carcinoma-associated fibroblasts (CAFs) on breast cancer stem cells. Method Relevant literatures about the relationship between the CAFs and breast cancer stem cells were collected and reviewed. Results CAFs were the majority type of the breast cancer stromal cells. The cancer stromal cell was also the important part of the tumor microenvironment, which could promote the proliferation, adhesion, invasion, and metastasis of the breast cancer. A subpopulation of cancer stem cells with the potentials of self-renewal and multi-directional differentiation in the breast cancer tissues might cause the tumor development. There was a phenotypic heterogeneity in the beast cancer stem cells, it was related to the tumor recurrence and therapy resistance. The CAFs could promote the formation of breast cancer stem cells through the epithelial mesenchymal transition and promote the transformation of tumor stem cell phenotype. More research needed to be done to prove these processes. Conclusion CAFs play an important role in formation of breast cancer stem cells and transformation of tumor stem cell phenotype, which might provide a new idea about treating breast cancer.
出处 《中国普外基础与临床杂志》 CAS 2018年第1期108-112,共5页 Chinese Journal of Bases and Clinics In General Surgery
关键词 乳腺癌 肿瘤干细胞 成纤维细胞 上皮间质转化 肿瘤微环境 breast cancer cancer stem cell fibroblast epithelial mesenchymal transition tumor micro- environment
  • 相关文献

参考文献4

二级参考文献89

  • 1Matjaz Rokavec,Weilin Wu,Jun-Li Luo.IL6-Mediated Suppression of miR-200c Directs Constitutive Activation of Inflammatory Signaling Circuit Driving Transformation and Tumorigenesis[J]. Molecular Cell . 2012 (6)
  • 2Qinglin Li,Jixiang Xia,Yuan Yao,Da-wei Gong,Hongfei Shi,Qun Zhou.Sulforaphane inhibits mammary adipogenesis by targeting adipose mesenchymal stem cells[J]. Breast Cancer Research and Treatment . 2013 (2)
  • 3Cinzia Giordano,Donatella Vizza,Salvatore Panza,Ines Barone,Daniela Bonofiglio,Marilena Lanzino,Diego Sisci,Francesca De Amicis,Suzanne A.W. Fuqua,Stefania Catalano,Sebastiano Andò.Leptin increases HER2 protein levels through a STAT3-mediated up-regulation of Hsp90 in breast cancer cells[J]. Molecular Oncology . 2013 (3)
  • 4Gale Newman,Ruben Rene Gonzalez-Perez.Leptin–cytokine crosstalk in breast cancer[J]. Molecular and Cellular Endocrinology . 2013
  • 5Rieke Alten,Tazio Maleitzke.Tocilizumab: A novel humanized anti-interleukin 6 (IL-6) receptor antibody for the treatment of patients with non-RA systemic, inflammatory rheumatic diseases[J]. Annals of Medicine . 2013 (4)
  • 6Yuan-Yuan Wang,Camille Lehuédé,Victor Laurent,Béatrice Dirat,Stéphanie Dauvillier,Ludivine Bochet,Sophie Le Gonidec,Ghislaine Escourrou,Philippe Valet,Catherine Muller.Adipose tissue and breast epithelial cells: A dangerous dynamic duo in breast cancer[J]. Cancer Letters . 2012 (2)
  • 7Suling Liu,Shawn G. Clouthier,Max S. Wicha.Role of microRNAs in the Regulation of Breast Cancer Stem Cells[J]. Journal of Mammary Gland Biology and Neoplasia . 2012 (1)
  • 8Laszlo Otvos,Ilona Kovalszky,Mirko Riolfi,Rita Ferla,Julia Olah,Andras Sztodola,Kaushik Nama,Annamaria Molino,Quirino Piubello,John D. Wade,Eva Surmacz.Efficacy of a leptin receptor antagonist peptide in a mouse model of triple-negative breast cancer[J]. European Journal of Cancer . 2011 (10)
  • 9Melinda Protani,Michael Coory,Jennifer H. Martin.Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis[J]. Breast Cancer Research and Treatment . 2010 (3)
  • 10AndreasGuenther,SharonGordon,MarkusTiemann,RenateBurger,FrankBakker,Jonathan R.Green,WolfgangBaum,Anke J.Roelofs,Michael J.Rogers,MartinGramatzki.The bisphosphonate zoledronic acid has antimyeloma activity in vivo by inhibition of protein prenylation[J]. Int. J. Cancer . 2009 (1)

共引文献13

同被引文献76

引证文献4

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部